| 000 | 01595 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516084808.0 | ||
| 264 | 0 | _c20121018 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1538-3636 | ||
| 024 | 7 |
_a10.1001/archgenpsychiatry.2012.169 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHowes, Oliver D | |
| 245 | 0 | 0 |
_aThe nature of dopamine dysfunction in schizophrenia and what this means for treatment. _h[electronic resource] |
| 260 |
_bArchives of general psychiatry _cAug 2012 |
||
| 300 |
_a776-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xbiosynthesis |
| 650 | 0 | 4 |
_aDopamine Antagonists _xpharmacokinetics |
| 650 | 0 | 4 |
_aDopamine Plasma Membrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuropharmacology _xmethods |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xbiosynthesis |
| 650 | 0 | 4 |
_aPresynaptic Terminals _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aTomography, Emission-Computed, Single-Photon _xmethods |
| 700 | 1 | _aKambeitz, Joseph | |
| 700 | 1 | _aKim, Euitae | |
| 700 | 1 | _aStahl, Daniel | |
| 700 | 1 | _aSlifstein, Mark | |
| 700 | 1 | _aAbi-Dargham, Anissa | |
| 700 | 1 | _aKapur, Shitij | |
| 773 | 0 |
_tArchives of general psychiatry _gvol. 69 _gno. 8 _gp. 776-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archgenpsychiatry.2012.169 _zAvailable from publisher's website |
| 999 |
_c21676355 _d21676355 |
||